Cytokinetics (CYTK) PT Raised to $48 at JMP Securities
Tweet
Share
E-mail
Get Alerts CYTK Hot Sheet
Price: $76.84 -0.44%
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
JMP Securities analyst Jason Butler raised the price target on Cytokinetics (NASDAQ: CYTK) to $48.00 (from $44.00) while maintaining a Market Outperform rating on the expanding Ji Xing cardiovascular partnership.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cytokinetics Announces Upcoming Presentations at the European Society of Cardiology (ESC) Congress 2026
- China Resources Beer Holdings Co Ltd. (291:HK) (CRHKY) PT Lowered to HK$31 at Macquarie
- Alibaba (9988:HK) (BABA) PT Raised to HK$188.70 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
